CTCF and breast cancer: In order to do so, we generated cell lines with a doxycycline-inducible RFP plus shRNA targeting CTCF. Given the suppression of CTCF following TGFβ treatment and in mesenchymal breast cancer cell lines, we expected the knockdown to induce mesenchymal traits.